Pre-clinical studies testing hemp-derived cannabinoids to block COVID-19 from entering human cells will occur within a few months, according to the Oregon State University scientist who led groundbreaking research. Richard van Breeman, a researcher with Oregon State University’s Global Hemp Innovation Center, the College of Pharmacy and the Linus Pauling Institute, announced Monday that trials could involve both cell cultures and animal models to test the safety and efficacy of a new drug candidate...
Thailand appears to be clearing the way for industrial hemp as the Narcotics Control Committee (NCC) agreed to remove cannabis from the country’s list of controlled substances but said plant parts containing more than 0.2% THC are still narcotics...
As research broke over the past two weeks that cannabis products including CBD, cannabinoid acids and even synthetic cannabis compounds may prevent or treat COVID-19 infections, excitement among hemp entrepreneurs spread. Interest in the seemingly stagnant hemp biomass, CBD and CBG markets soared to highs not seen in three years. Prices are on the rise again and hemp producers are fielding calls from a slew of interested parties hoping to cash in on the news...
There's an ongoing quest for performance-enhancing substances that can provide that elusive edge for high-level athletes. With mere milliseconds sometimes defining the difference between a touchdown and an interception, athletes look for any legal substance that can provide that extra little push. But finding such enhancements isn't easy. Supplements must conform to stringent anti-doping laws and also be safe...
U.S. e-commerce giant Amazon employs about 1 million Americans to keep its business up and running. As more of those people use cannabis in marijuana-legal states, the Seattle-based retailer knows its pool of potential candidates could gradually be shrinking without help from the feds...
CBD stakeholders in the UK are anticipating the release of a list of compliant products from food safety authorities expected any day as they look to gain footholds in the world’s second-biggest CBD market. “The UK’s consumer health sector is set for its biggest shake-up in more than a decade when the Food Standards Agency (FSA) releases its eagerly-awaited public list of cannabinoid products permitted for sale to consumers,” the Association for the Cannabinoid Industry (ACI) said in a press release announcing it has opened a website that will track those products approved for the market...
A new analysis from Leafreport found a 5,100% difference between the cheapest and most expensive CBD products on the market but found a 1.96% price decrease per milligram of CBD since last April. The report shows the cheapest CBD category is CBD isolate, which Leafreport found was 19% cheaper on average compared to April 2021, while capsules have increased the most over the same period — by 2.55%...
Another university is joining the call to investigate CBD’s potential to treat or prevent COVID-19, but the University of Chicago is also warning consumers not to expect COVID-19 protection from over-the-counter CBD products. And retailers should remain cautious about promoting such health benefits of their products...
Cannabidiol—the non-psychoactive cannabis compound better known as CBD—is a potent blocker of SARS-CoV-2 replication in human cells, new research shows. Not only that, but a survey of real-world patients taking prescribed CBD found a “significant” negative relationship between CBD consumption and COVID-19 infection...
Gummies are the undisputed champions of edible cannabis, with sales that dwarf all other category form factors. According to Seattle-based cannabis analytics firm Headset, gummies accounted for $602 million in sales through the first nine months of 2021. The next-largest edibles segment was chocolate with less than $100 million in reported sales for the same period...
The U.S. Food & Drug Administration (FDA) said a CBD-based treatment for opioid use disorder can be used in clinical trials, Ananda Scientific Inc., the drug’s maker, announced this week. Ananda Scientific said FDA granted an investigational drug designation (IND) for Nantheia ATL5, a liquid administered through the biotech pharma company’s proprietary delivery technology.The U.S. Food & Drug Administration (FDA) said a CBD-based treatment for opioid use disorder can be used in clinical trials, Ananda Scientific Inc., the drug’s maker, announced this week. Ananda Scientific said FDA granted an investigational drug designation (IND) for Nantheia ATL5, a liquid administered through the biotech pharma company’s proprietary delivery technology...
Two compounds present in industrial hemp show the ability to prevent the virus that causes covid-19 from entering human cells, according to researchers in Oregon. “These cannabinoid acids are abundant in hemp and in many hemp extracts,” said Richard van Breemen, a researcher with Oregon State University’s Global Hemp Innovation Center, College of Pharmacy and Linus Pauling Institute, who led the study. “They are not controlled substances like THC, the psychoactive ingredient in marijuana, and have a good safety profile in humans.”...
My almost lifelong search for the perfect shampoo has recently landed me on a relatively new cast of products: CBD-based and -infused shampoos. This may be unsurprising, given the attention that all things CBD have received in the past few years...
New research out of Oregon State University has identified that two hemp compounds – CBDa and CBGa – show the ability to prevent the virus that causes COVID-19 from entering human cells. Findings of a study that included a chemical screening technique invented by researchers at OSU were published Tuesday in the Journal of Natural Products...
Local officials in west-central Italy say they are progressing with plans to build a sustainable hemp supply chain model that can transform the agriculture of an entire region.
Officials in the city of Roccasecca, in the province of Frosinone of the Lazio region, said preparation of land for a first planting of hemp is now underway in anticipation of the 2022 growing season...
Marijuana legalization through state legislatures heated up in 2021, and that trend likely will continue this year as lawmakers in several states are expected to legalize either recreational or medical cannabis. The Northeast and mid-Atlantic states are in the spotlight for adult-use marijuana legislative activity, with Rhode Island the top candidate to approve a regulated commercial market, according to industry experts...
Now that the new year is here, cannabis industry executives can expect to face a crosscurrent of trends in 2022. Some will be positive for the industry; others, negative. Some will be new; others, a continuation from 2021...